Rezultati pretrage - Gesa Schalk

  • Prikaz rezultata 1 – 8 od 8
Detaljiziraj rezultate
  1. 1
    Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)

    Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4) od David S. Goldfarb, John C. Lieske, Jaap W. Groothoff, Gesa Schalk, Kerry Russell, Shuli Yu, Blaz Vrhnjak

    Izdano 2023
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3

    Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3 od Jaap W. Groothoff, Anne‐Laure Sellier‐Leclerc, Lisa J. Deesker, Justine Bacchetta, Gesa Schalk, Burkhard Tönshoff, Graham Lipkin, Sandrine Lemoine, Thomas Bowman, Jing Zhou, Bernd Höppe

    Izdano 2024
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

    Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders od Cyrill Wehling, Oliver Amon, Martin Bommer, Bernd Höppe, Karim Kentouche, Gesa Schalk, Rolf Weimer, Michael S. Wiesener, Bernd Hohenstein, Burkhard Tönshoff, Rainer Büscher, Horst Fehrenbach, Ö-N Gök, Michael Kirschfink

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

    Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria od Bernd Höppe, Annelize Koch, Pierre Cochat, Sander F. Garrelfs, Michelle A. Baum, Jaap W. Groothoff, Graham Lipkin, Martin Coenen, Gesa Schalk, Aniruddha Amrite, David McDougall, Kelly Barrios, Craig B. Langman

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

    Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 od Sander F. Garrelfs, Yaacov Frishberg, Sally A. Hulton, Michael J. Koren, William O’Riordan, Pierre Cochat, Georges Deschênes, Hadas Shasha‐Lavsky, Jeffrey M. Saland, William G. van’t Hoff, Daniel G. Fuster, Daniella Magen, Shabbir H. Moochhala, Gesa Schalk, Eva Šimková, Jaap W. Groothoff, David J. Sas, Kristin Meliambro, Jiandong Lu, Marianne T. Sweetser, Pushkal Garg, Akshay Vaishnaw, John M. Gansner, Tracy L. McGregor, John C. Lieske

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children

    Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children od David J. Sas, Daniella Magen, Wesley Hayes, Hadas Shasha‐Lavsky, Mini Michael, Indra Schulte, Anne‐Laure Sellier‐Leclerc, Jiandong Lu, Ali Seddighzadeh, Bahru Habtemariam, Tracy L. McGregor, Kenji P. Fujita, Yaacov Frishberg, Justine Bacchetta, Véronique Baudouin, Rachel Becker‐Cohen, Shimrit Tzvi Behr, Efrat Ben‐Shalom, Maria Berdaguer, Detlef Böckenhauer, Pierre Cochat, Martin Coenen, Carl H. Cramer, Georges Deschênes, Claire Dossier, Emilie Doye, Liat Feraru Feldman, Maximilian Hohenadel, Florentia Kaguelidou, Irina Libinson Zebegret, John C. Lieske, Anne Maisin, Dawn S. Milliner, Moran Plonsky Toder, Shirley Pollack, Aurélie Portefaix, Bruno Ranchin, Choni Rinat, Adnan Safdar, Gesa Schalk, Poyyapakkam Srivaths, Cheryl L. Tran, William van’t Hoff, Jenny Weinbrand-Goichberg, Irith Weissman

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

    A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in childr... od Oliver Groß, Burkhard Tönshoff, Lutz T. Weber, Lars Pape, Kay Latta, Henry Fehrenbach, Baerbel Lange‐Sperandio, H. Zappel, Peter F. Hoyer, Hagen Staude, Sabine König, Ulrike John, Jutta Gellermann, Bernd Höppe, Matthias Galiano, Britta Hoecker, Rasmus Ehren, Christian Lerch, Clifford E. Kashtan, Markus Harden, Jan Boeckhaus, Tim Friede, Michael Koziolek, Carsten Bramlage, Frauke Weber, Tanja Albrecht-Nock, Joseph Sonntag, Jenny Frese, Matthias Kettwig, Reinhard Hilgers, Matthias Hansen, Mirja Wedekin, Nicole Meyer, S. Klaiber, Michaela Geßner, Max C. Liebau, Anne-Kristin Vogt-Weigeldt, Therese Jungraithmayr, Sabine Ponsel, Ulrike Jacoby, Martin Konrad, Brigitta Kranz, Jens Koenig, Lisa Loechtermann, Michael Pohl, Ralf A. Husain, Katrin Mueller, Julia Thumfart, Gesa Schalk, Markus Feldkoetter, Sabine Schmidt, Katja Sauerstein, Evelin Muschiol, Heiko Billing, Frauke Wilkening

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease

    Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease od Kathrin Burgmaier, Kevin Kunzmann, Gema Ariceta, Carsten Bergmann, Anja Buescher, Mathias Burgmaier, İsmail Dursun, Ali Düzova, Loai Eid, Florian Erger, Markus Feldkoetter, Matthias Galiano, Michaela Geßner, Heike Goebel, İbrahim Gökçe, Dieter Haffner, Nakysa Hooman, Bernd Höppe, Augustina Jankauskiené, Günter Klaus, Jens König, Mieczysław Litwin, Laura Massella, Djalila Mekahli, Engin Melek, Sevgı Mır, Lars Pape, Larisa Prikhodina, Bruno Ranchin, Raphael Schild, Tomáš Seeman, Lale Sever, Rukshana Shroff, Neveen A. Soliman, Stella Stabouli, Małgorzata Stańczyk, Yılmaz Tabel, Katarzyna Taranta‐Janusz, Sara Testa, Julia Thumfart, Rezan Topaloĝlu, Lutz T. Weber, Dorota Wicher, Elke Wühl, Simone Wygoda, Alev Yılmaz, Katarzyna Zachwieja, Ilona Zagożdżon, Klaus Zerres, Jörg Dötsch, Franz Schaefer, Max C. Liebau, Nadejda Ranguelov, Nathalie Godefroid, Laure Collard, Jacques Lombet, Julie Maquet, Gesa Schalk, Uwe Querfeld, Bodo B. Beck, Thomas Benzing, Reinhard Buettner, Franziska Grundmann, Christine Kurschat, Kerstin Benz, Anja Tzschoppe, Bjoern Buchholz, Rainer Buescher, Karsten Häffner, Martin Pöhl, Oliver Groß, Jenny Krügel, Johanna Stock, Ludwig Patzer, Jun Oh, Wanja M. Bernhardt, Anke Doyon, Tobias Vinke, Anja Sander, Michael Henn, Ute Derichs, Rolf Beetz, Nikola Jeck, Bärbel Lange-Sperandio, Sabine Ponsel, Franziska Kusser, Barbara Uetz, Marcus R. Benz, Silke Schmidt, C. J. Huppertz-Kessler, Birgitta Kranz, Andrea Titieni, Donald Wurm, Heinz E. Leichter, Martin Bald, Heiko Billing, Marwa M. Nabhan, Luis Enrique Lara, Fotiοs Papachristou, Francesco Emma

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: